✦ LIBER ✦

Intradermal Influenza Vaccine Elicits Superior Immunogenicity in Adults Aged ≥60 Years: A Randomized Controlled Phase 3 Trial

✍ Scribed by R. Arnou; M. De Decker; G. Icardi; A. Ambrozaitis; M. Kazek; M. Saville

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and Safety of Intradermal

✍ Chan, Tuen-Ching; Hung, Ivan Fan-Ngai; Chan, Kwok-Hung; Li, Clara Pui-Yan; Li, P 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 869 KB

Immunogenicity, reactogenicity, and safe

✍ Tinoco, Juan Carlos; Pavia-Ruz, Noris; Cruz-Valdez, Aurelio; Aranza Doniz, Carlo 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 603 KB

Intradermal influenza vaccination of hea

✍ Jiri Beran; Arvydas Ambrozaitis; Alvydas Laiskonis; Narseta Mickuviene; Patrick 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 381 KB

Response to Comments on “Immunogenicity

✍ Chan, Tuen-Ching; Hung, Ivan Fan-Ngai; Chan, Kwok-Hung; Li, Clara Pui-Yan; Li, P 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Flexibility of interval between vaccinat

✍ Xavier Duval, Adrian Caplanusi, Henri Laurichesse, Dominique Deplanque, Pierre L 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 302 KB

A randomized, double-blind trial to eval

✍ T.F. Schwarz; J. Flamaing; H.C. Rümke; J. Penzes; C. Juergens; A. Wenz; D. Jayaw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB